Louisiana 2026 Regular Session

Louisiana House Bill HB1231

Introduced
3/31/26  
Refer
4/1/26  
Report Pass
4/15/26  
Refer
4/16/26  
Report Pass
4/27/26  
Engrossed
5/5/26  
Refer
5/6/26  
Report Pass
5/20/26  

Caption

MEDICAID MANAGED CARE: Provides relative to Medicaid coverage for pregnant women (EN NO IMPACT See Note)

Impact

The impact of HB 1231 on state laws will be significant as it modifies the current Medicaid coverage framework to ensure that pregnant women with diabetes receive adequate support. By including continuous glucose monitors in Medicaid coverage, the bill addresses a critical point of care for managing diabetes during pregnancy, which can be essential for protecting both maternal and fetal health. This change could potentially lead to improved health outcomes for women and children by facilitating better management of diabetes in pregnant patients.

Summary

House Bill 1231 aims to improve Medicaid coverage for pregnant women by providing coverage for continuous glucose monitoring devices under specific circumstances. The bill seeks to amend existing regulations to include comprehensive support for women dealing with gestational diabetes or other diabetes conditions that necessitate close monitoring. This legislative effort reflects a recognition of the unique healthcare needs during pregnancy and aims to enhance maternal health outcomes by ensuring that necessary medical devices are accessible through Medicaid.

Sentiment

The sentiment surrounding HB 1231 appears to be largely positive, with broad support among legislators and healthcare advocates who view the provision as necessary for improving maternal healthcare. Many stakeholders believe that this legislative change will alleviate some of the burden faced by pregnant women with diabetes, allowing for better health monitoring and management. There is, however, a nuanced conversation surrounding the implications for Medicaid funding and sustainability, which some critics have raised as a concern.

Contention

While overall support for HB 1231 is evident, there is contention regarding the potential long-term financial effects on the Medicaid program. Critics are concerned that expanding coverage may increase costs for the state and taxpayers, particularly if there is insufficient funding to support the broader implications of the bill. Additionally, the bill sparks broader discussions about healthcare accessibility and the necessary prioritization of services to enhance maternal health without compromising the sustainability of essential programs.

Companion Bills

No companion bills found.

Previously Filed As

LA HB595

Provides relative to Medicaid coverage through the TEFRA option program (EN SEE FISC NOTE GF EX)

LA HB454

Requires Medicaid coverage for certain doula services (EN INCREASE GF EX See Note)

LA SB182

Provides relative to Medicaid prior authorization during a declared emergency. (8/1/25) (EN NO IMPACT See Note)

LA SB130

Provides relative to Medicaid. (gov sig) (EN DECREASE GF EX See Note)

LA SB174

Provides relative to certain pregnancy screenings. (gov sig) (EN INCREASE GF EX See Note)

LA HB259

Provides relative to bonds for notaries public (EN NO IMPACT See Note)

LA HB622

Requires health insurance coverage for histotripsy procedures (EN NO IMPACT See Note)

LA HR292

Urges and requests the La. Dept. of Health to increase Medicaid coverage for healthcare services required by individuals with gestational diabetes mellitus

LA SB173

Provides for reimbursement rates paid by Pharmacy Benefit Managers. (8/1/25) (OR NO IMPACT SG EX See Note)

LA SB36

Provides for carbon sequestration. (8/1/25) (EN NO IMPACT See Note)

Similar Bills

No similar bills found.